Evaluation of applicability of HE4 and ROMA in the preoperative diagnosis of adnexal masses

Lukasz Janas, Łukasz Janas, Ewa Głowacka, Jacek R Wilczyński, Andrzej Malinowski, Marek Nowak
Ginekologia polska · 2015 · vol. 86(3) , pp. 193–197 · doi:10.17772/gp/2062 · PMID:25920309 · W313928563
article OA: gold CC0
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This study evaluated HE4 and ROMA for preoperative diagnosis of adnexal masses, finding HE4 improved accuracy over CA 125, particularly in cases of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: The aim of the study was to evaluate the effectiveness of HE4 alone and in combination with CA 125 (ROMA) in selecting patients at high risk of adnexal malignancy. MATERIAL AND METHODS: Serum CA 125 and HE4 levels were determined and the ROMA value was calculated in 259 women qualified for surgery due to adnexal mass. The results were compared with histopathological findings. RESULTS: Sensitivity and specificity in preoperative diagnosis of primary ovarian cancer were 93.2% and 71.5% for CA 125 and 95.4% and 81.3% for HE4, respectively ROMA algorithm achieved sensitivity of 95.4% and specificity of 79.8%. All methods reached sensitivity of 100% at specificity of 65.6% for CA125, 93.4% for HE4 and 82.0% for ROMA in premenopausal women, whereas in postmenopausal women sensitivity and specificity achieved levels of 92.1% and 81.7% for CA 125, 94.7% and 60.6% for HE4 and 94.7% and 76.1% for ROMA, respectively Serum levels of both CA 125 and HE4 were significantly higher in women with primary ovarian cancer as compared to benign disease. Concentrations of CA 125 in patients with endometriosis were significantly elevated as compared to women with other benign tumors. Such relation was not observed when HE4 levels were concerned. CONCLUSIONS: CA 125, HE4 and ROMA are useful in preoperative diagnosis of ovarian malignancy HE4 improves the diagnostic accuracy in cases of endometriosis, verifying false positive results of CA 125.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Adnexal Diseases Biomarkers, Tumor CA-125 Antigen Proteins Adnexal Diseases Adnexal Diseases Adnexal Diseases Adult Algorithms Biomarkers, Tumor CA-125 Antigen Female Humans Middle Aged Ovarian Neoplasms Ovarian Neoplasms Poland Preoperative Care Preoperative Care Proteins

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (17)

Source provenance

europepmc
last seen: 2026-06-20T06:14:18.781669+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:17:52.213533+00:00
License: CC0 · commercial use OK